NCT05749302 2024-03-29
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3 Unknown
Clinical Trials
12 trialsNCT06103279 2023-10-26
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
Ain Shams University
Phase 2/3 Unknown
NCT04741880 2021-07-30
ELSA
Instituto Nacional de Cancer, Brazil
Phase 2/3 Unknown
NCT04710290 2021-01-25
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
E-DA Hospital
Phase 2/3 Unknown
NCT04060472 2019-08-19
Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors
Third Military Medical University
Phase 2/3 Unknown
NCT03662087 2018-09-07
HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown
NCT03624530 2018-08-10
Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown
NCT02777788 2017-10-10
TCM
Shanghai University of Traditional Chinese Medicine
Phase 2/3 Unknown
NCT02250872 2016-04-20
Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury
Seoul National University Bundang Hospital
Phase 2/3 Unknown
NCT01830231 2014-01-28
Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)
Associació per a la Recerca Oncologica, Spain
Phase 2/3 Unknown
NCT01523015 2013-02-05
Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction
Medical University of Lublin
Phase 2/3 Unknown
NCT00215007 2007-11-30
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Charite University, Berlin, Germany
Phase 2/3 Unknown